Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Steatosis associates with insulin resistance and may even predict type 2 diabetes and cardiovascular complications. Because muscular insulin resistance relates to myocellular fat deposition and disturbed energy metabolism, we hypothesized that reduced hepatic ATP turnover (fATP) underlies insulin resistance and elevated hepatocellular lipid (HCL) contents. RESEARCH DESIGN AND METHODS: We measured hepatic fATP using 31P magnetic resonance spectroscopy in patients with type 2 diabetes and age- and body mass–matched controls. Peripheral (M and M/I) and hepatic (suppression of endogenous glucose production) insulin sensitivity were assessed with euglycemic-hyperinsulinemic clamps. RESULTS: Diabetic individuals had 29% and 28% lower peripheral and hepatic insulin sensitivity as well as 42% reduced fATP than controls. After adjusting for HCL, fATP correlated positively with peripheral and hepatic insulin sensitivity but negatively with waist circumference, BMI, and fasting plasma glucose. Multiple regression analysis identified waist circumference as an independent predictor of fATP and inorganic phosphate (PI) concentrations, explaining 65% (P = 0.001) and 56% (P = 0.003) of the variations. Hepatocellular PI primarily determined the alterations in fATP. CONCLUSIONS: In patients with type 2 diabetes, insulin resistance relates to perturbed hepatic energy metabolism, which is at least partly accounted for by fat depots.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In these studies, hepatic ATP production more strongly associated with hepatic than peripheral insulin sensitivity (130, 131).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [130]
In the citing paper
“However, as in muscle, 31 P-NMR measurements of hepatic mitochondrial ATP production reveal 23%-26% decreased ATP production in T2D individuals compared with age-and weightmatched nondiabetic controls (130, 131).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 3×
“We studied elderly volunteers who had a mean age of ~60 years, whichmight result in lower fATP analogous to data on myocellular fATP (8).”
BackgroundResultMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 1×
“In skeletal muscle, insulin resistance relates not only to elevated lipids but also to impaired rates of phosphorylation (flux throughATP synthesis, fATP), asmeasured by (31)P MRS in elderly (6) type 2 diabetic patients (7), their insulin-resistant firstdegree relatives (8), and nondiabetic individuals with elevated p…”
BackgroundNonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Bays, H., Mandarino, L., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030723 · Cited by 664 · cited 2×
“In type 2 diabetes, insulin resistance develops as a result of inherited factors as well as from acquired factors that result in glucolipotoxicity due to chronic elevation of FFAs, triglycerides, or glucose (2,3).”
BackgroundDietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction
Kirk, E., Reeds, D. N., Finck, B. N., Mayurranjan, M. S., Patterson, B. W., & Klein, S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.048 · Cited by 440 · cited 1×
“A short-term high-fat diet also leads to insulin resistance in liver, but not in skeletal muscle (17), whereas a hypocaloric diet decreases both hepatic fat content and insulin resistance within 48 h (18).”
BackgroundThe prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis
Rankinen, T., Kim, S.-Y., Pérusse, L., Després, J.-P., & Bouchard, C. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800929 · Cited by 414 · cited 1×
“Of note, waist circumference is the best anthropometric marker of abdominal visceral fat (19), which suggests, but does not prove, a role of visceral fat for hepatic energy metabolism.”
BackgroundMechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance
Roden, M. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0190 · Cited by 405
Self-citationMuscle Mitochondrial ATP Synthesis and Glucose Transport/Phosphorylation in Type 2 Diabetes
Szendroedi, J., Schmid, A. I., Chmelik, M., Toth, C., Brehm, A., Krssak, M., Nowotny, P., Wolzt, M., Waldhausl, W., & Roden, M. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040154 · Cited by 243 · cited 5×
“A 20% dextrose infusion labeled with D-[6,6-(2)H2]glucose (2% enriched) according to the hot-glucose infusion protocol was periodically adjusted to maintain euglycemia (7).”
BackgroundMethodInfluentialSelf-citation
Cited by
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294
“This link between DAG-mediated activation of nPKCs and muscle insulin resistance has been replicated in human studies (Itani et al., 2002; Szendroedi et al., 2011).”
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2014) · Nature · doi:10.1038/nature13478 · Cited by 1,136
Koliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032
“, 2009) and flux through ATP synthase (Schmid et al., 2011), pointing to a possible role of circulating glucose.”
Self-citationMechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Kawano, Y., & Cohen, D. E. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0758-5 · Cited by 969
Tilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.147 · Cited by 1,002
Self-citationCusi, K. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.003 · Cited by 911
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
Softic, S., Cohen, D. E., & Kahn, C. R. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4054-0 · Cited by 709
“Patients with NAFLD exhibit reduced hepatic ATP levels [114, 115], perhaps owing to increased rates of DNL.”
BackgroundThe role of mitochondria in insulin resistance and type 2 diabetes mellitus
Szendroedi, J., Phielix, E., & Roden, M. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.138 · Cited by 600
Self-citationPros and cons of ultra-high-field MRI/MRS for human application
Ladd, M. E., Bachert, P., Meyerspeer, M., Moser, E., Nagel, A. M., Norris, D. G., Schmitter, S., Speck, O., Straub, S., & Zaiss, M. (2018) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2018.06.001 · Cited by 544
Self-citationTreatment of nonalcoholic fatty liver disease: role of AMPK
Smith, B. K., Marcinko, K., Desjardins, E. M., Lally, J. S., Ford, R. J., & Steinberg, G. R. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00225.2016 · Cited by 500
Mitochondrial alterations in fatty liver diseases
Fromenty, B., & Roden, M. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2022.09.020 · Cited by 424
Self-citationMitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis
Pinti, M. V., Fink, G. K., Hathaway, Q. A., Durr, A. J., Kunovac, A., & Hollander, J. M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00314.2018 · Cited by 427
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Pafili, K., & Roden, M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101122 · Cited by 330
Self-citationDiacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin Resistance
Jornayvaz, F. R., & Shulman, G. I. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.005 · Cited by 317
Sunny, N. E., Bril, F., & Cusi, K. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.11.006 · Cited by 319
Fatty liver index and mortality: The cremona study in the 15th year of follow-up
Calori, G., Lattuada, G., Ragogna, F., Garancini, M. P., Crosignani, P., Villa, M., Bosi, E., Ruotolo, G., Piemonti, L., & Perseghin, G. (2011) · Hepatology · doi:10.1002/hep.24356 · Cited by 253
Non-Alcoholic Fatty Liver Disease
Engin, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_19 · Cited by 248
Moore, M. P., Cunningham, R. P., Meers, G. M., Johnson, S. A., Wheeler, A. A., Ganga, R. R., Spencer, N. M., Pitt, J. B., Diaz‐Arias, A., Swi, A. I. A., et al. (2022) · Hepatology · doi:10.1002/hep.32324 · Cited by 240
“Collectively, there is evidence for altered hepatic mitochondrial function in the setting of obesity,[15,42] insulin resistance,[18,43] and NAFLD/NASH.”
BackgroundLepretti, M., Martucciello, S., Burgos Aceves, M., Putti, R., & Lionetti, L. (2018) · Nutrients · doi:10.3390/nu10030350 · Cited by 232
“Moreover, reduction in absolute hepatic ATP concentrations and in ATP turnover were found in type 2 diabetes patients [43].”
BackgroundMolecular Pathogenesis of NASH
Caligiuri, A., Gentilini, A., & Marra, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091575 · Cited by 209
Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance
Hernández, E. Á., Kahl, S., Seelig, A., Begovatz, P., Irmler, M., Kupriyanova, Y., Nowotny, B., Nowotny, P., Herder, C., Barosa, C., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89444 · Cited by 194
Self-citationAltered mitochondrial function in insulin-deficient and insulin-resistant states
Ruegsegger, G. N., Creo, A. L., Cortes, T. M., Dasari, S., & Nair, K. S. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120843 · Cited by 202
Interorgan Metabolic Crosstalk in Human Insulin Resistance
Gancheva, S., Jelenik, T., Álvarez-Hernández, E., & Roden, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00015.2017 · Cited by 192
Self-citationCounteracting Roles of AMP Deaminase and AMP Kinase in the Development of Fatty Liver
Lanaspa, M. A., Cicerchi, C., Garcia, G., Li, N., Roncal-Jimenez, C. A., Rivard, C. J., Hunter, B., Andrés-Hernando, A., Ishimoto, T., Sánchez-Lozada, L. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048801 · Cited by 193
Cicerchi, C., Li, N., Kratzer, J., Garcia, G., Roncal‐Jimenez, C. A., Tanabe, K., Hunter, B., Rivard, C. J., Sautin, Y. Y., Gaucher, E. A., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-243634 · Cited by 187
Ye, Z., Wang, S., Zhang, C., & Zhao, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00617 · Cited by 172
Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus
Koliaki, C., & Roden, M. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050656 · Cited by 165
Self-citationMetabolic liver disease in diabetes – From mechanisms to clinical trials
Dewidar, B., Kahl, S., Pafili, K., & Roden, M. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154299 · Cited by 158
Self-citationLipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity
Patterson, R. E., Kalavalapalli, S., Williams, C. M., Nautiyal, M., Mathew, J. T., Martinez, J., Reinhard, M. K., McDougall, D. J., Rocca, J. R., Yost, R. A., et al. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00492.2015 · Cited by 161
Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver
Jelenik, T., Kaul, K., Séquaris, G., Flögel, U., Phielix, E., Kotzka, J., Knebel, B., Fahlbusch, P., Hörbelt, T., Lehr, S., et al. (2017) · Diabetes · doi:10.2337/db16-1147 · Cited by 154
Self-citationNonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
Ciaula, A. D., Passarella, S., Shanmugam, H., Noviello, M., Bonfrate, L., Wang, D. Q. ‐., & Portincasa, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105375 · Cited by 153
Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease
Koliaki, C. C., & Roden, M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.002 · Cited by 144
Self-citationXia, M.-F., Bian, H., & Gao, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00877 · Cited by 132
Physiology and pathophysiology of liver lipid metabolism
Ponziani, F. R., Pecere, S., Gasbarrini, A., & Ojetti, V. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1056156 · Cited by 147
Purinergic signalling and diabetes
Burnstock, G., & Novak, I. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9359-2 · Cited by 138
Trouwborst, I., Bowser, S. M., Goossens, G. H., & Blaak, E. E. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00077 · Cited by 111
Papamichail, L., Koch, L. S., Veerman, D., Broersen, K., & van der Meer, A. D. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1515340 · Cited by 120
The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes
Martin, S. D., & McGee, S. L. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.09.019 · Cited by 113
FAM3A Activates PI3K p110α/Akt Signaling to Ameliorate Hepatic Gluconeogenesis and Lipogenesis
Wang, C., Chi, Y., Li, J., Miao, Y., Li, S., Su, W., Jia, S., Chen, Z., Du, S., Zhang, X., et al. (2014) · Hepatology · doi:10.1002/hep.26945 · Cited by 115
van der Veen, J. N., Lingrell, S., da Silva, R. P., Jacobs, R. L., & Vance, D. E. (2014) · Diabetes · doi:10.2337/db13-0993 · Cited by 114
In-vivo 31P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism
Valkovič, L., Chmelík, M., & Krššák, M. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2017.01.018 · Cited by 120
Self-citationLegaki, A.-I., Moustakas, I. I., Sikorska, M., Papadopoulos, G., Velliou, R.-I., & Chatzigeorgiou, A. (2022) · Current Obesity Reports · doi:10.1007/s13679-022-00473-1 · Cited by 103
Goedeke, L., & Shulman, G. I. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101178 · Cited by 93
Befroy, D. E., Perry, R. J., Jain, N., Dufour, S., Cline, G. W., Trimmer, J. K., Brosnan, J., Rothman, D. L., Petersen, K. F., & Shulman, G. I. (2014) · Nature Medicine · doi:10.1038/nm.3415 · Cited by 96
Mitochondrial Dysfunction in the Transition from NASH to HCC
Léveillé, M., & Estall, J. L. (2019) · Metabolites · doi:10.3390/metabo9100233 · Cited by 100
Retrograde mitochondrial signaling governs the identity and maturity of metabolic tissues
Walker, E. M., Pearson, G. L., Lawlor, N. T., Stendahl, A. M., Lietzke, A. C., Sidarala, V., Zhu, J., Stromer, T., Reck, E. C., Li, J., et al. (2025) · Science · doi:10.1126/science.adf2034 · Cited by 105
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
Guerra, J. V. D. S., Dias, M. M. G., Brilhante, A. J. V. C., Terra, M. F., García‐Arévalo, M., & Figueira, A. C. M. (2021) · Nutrients · doi:10.3390/nu13082830 · Cited by 112
Phielix, E., Szendroedi, J., & Roden, M. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.06.006 · Cited by 97
Self-citationTargeting Mitochondria in Diabetes
Jakovljevic, N. K., Pavlović, K., Jotić, A., Lalic, K. S., Stoiljkovic, M. M., Lukić, L., Milicic, T. J., Macesic, M. V., Gajović, J. S., & Lalic, N. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126642 · Cited by 105
Mitochondrial heterogeneity in diseases
Chen, L., Zhou, M., Li, H., Liu, D., Liao, P., Yao, Z., Zhang, C., Zou, W., & Gao, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01546-w · Cited by 93
Profiling and Identification of Small rDNA-Derived RNAs and Their Potential Biological Functions
Wei, H., Zhou, B. Z., Zhang, F., Tu, Y., Hu, Y., Zhang, B., & Zhai, Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056842 · Cited by 96
Fan, L., Cacicedo, J. M., & Ido, Y. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13303 · Cited by 86
Acierno, C., Caturano, A., Pafundi, P. C., Nevola, R., Adinolfi, L. E., & Sasso, F. C. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00019 · Cited by 73
FAM3 gene family: A promising therapeutical target for NAFLD and type 2 diabetes
Zhang, X., Yang, W., Wang, J., Meng, Y., Guan, Y., & Yang, J. (2017) · Metabolism · doi:10.1016/j.metabol.2017.12.001 · Cited by 85
Soto-Urquieta, M. G., López-Briones, S., Pérez‐Vázquez, V., Saavedra‐Molina, A., Hernández, G. A. G., & Ramírez-Emiliano, J. (2014) · Biological Research · doi:10.1186/0717-6287-47-74 · Cited by 79
Predictors of Whole-Body Insulin Sensitivity Across Ages and Adiposity in Adult Humans
Lalia, A. Z., Dasari, S., Johnson, M. L., Robinson, M. M., Konopka, A. R., Distelmaier, K., Port, J. D., Glavin, M. T., Esponda, R. R., Nair, K. S., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2892 · Cited by 74
Use of in vivo magnetic resonance spectroscopy for studying metabolic diseases
Hwang, J.-H., & Choi, C. S. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.101 · Cited by 72
Mitochondrial Plasticity in Obesity and Diabetes Mellitus
Jelenik, T., & Roden, M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4910 · Cited by 73
Self-citationInsulin Regulates Hepatic Triglyceride Secretion and Lipid Content via Signaling in the Brain
Scherer, T., Lindtner, C., O’Hare, J., Hackl, M., Zielinski, E., Freudenthaler, A., Baumgartner-Parzer, S., Tödter, K., Heeren, J., Krššák, M., et al. (2016) · Diabetes · doi:10.2337/db15-1552 · Cited by 66
Self-citationvon Loeffelholz, C., Coldewey, S. M., & Birkenfeld, A. L. (2021) · Cells · doi:10.3390/cells10071822 · Cited by 73
Brouwers, B., Schrauwen-Hinderling, V. B., Jelenik, T., Gemmink, A., Sparks, L. M., Havekes, B., Bruls, Y., Dahlmans, D., Roden, M., Hesselink, M. K. C., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00266.2017 · Cited by 69
Self-citation31P-Magnetization Transfer Magnetic Resonance Spectroscopy Measurements of In Vivo Metabolism
Befroy, D. E., Rothman, D. L., Petersen, K. F., & Shulman, G. I. (2012) · Diabetes · doi:10.2337/db12-0558 · Cited by 70
Ryu, M. J., Kim, S. J., Kim, Y. K., Choi, M. J., Tadi, S., Lee, M. H., Lee, S. E., Chung, H. K., Jung, S. B., Kim, H. J., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003356 · Cited by 68
Shannon, C. E., Ragavan, M., Palavicini, J. P., Fourcaudot, M. J., Bakewell, T. M., Valdez, I., Ayala, I., Jin, E. S., Madesh, M., Han, X., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101154 · Cited by 68
Wang, C., Chen, Z., Li, S., Zhang, Y., Shi, J., Li, J., Chi, Y., Miao, Y., Guan, Y., & Yang, J. (2013) · Diabetes · doi:10.2337/db13-1096 · Cited by 69
Arid1a regulates insulin sensitivity and lipid metabolism
Qu, Y.-L., Deng, C.-H., Luo, Q., Shang, X., Wu, J., Shi, Y. Y., Wang, L., & Han, Z. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.021 · Cited by 63
Reyes-Caballero, H., Rao, X., Sun, Q., Warmoes, M. O., Lin, P., Sussan, T. E., Park, B., Fan, T. W. ‐., Maiseyeu, A., Rajagopalan, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-53716-y · Cited by 65
Guerra, S., Mocciaro, G., & Gastaldelli, A. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13695 · Cited by 65
Tsilingiris, D., Tzeravini, E., Koliaki, C. C., Dalamaga, Μ., & Kokkinos, A. D. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00434-0 · Cited by 64
Diabetes as a risk factor for MASH progression
Gancheva, S., Roden, M., & Castéra, L. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111846 · Cited by 65
Self-citationJelenik, T., Séquaris, G., Kaul, K., Ouwens, D. M., Phielix, E., Kotzka, J., Knebel, B., Weiß, J., Reinbeck, A. L., Janke, L., et al. (2014) · Diabetes · doi:10.2337/db13-1794 · Cited by 56
Self-citationMitochondrial dysfunction has divergent, cell type-dependent effects on insulin action
Martin, S. D., Morrison, S., Konstantopoulos, N., & McGee, S. L. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.02.001 · Cited by 58
MR Imaging Evaluation of Cardiovascular Risk in Metabolic Syndrome
van der Meer, R. W., Lamb, H. J., Smit, J. W. A., & de Roos, A. (2012) · Radiology · doi:10.1148/radiol.12110772 · Cited by 57
Hypermethylation of Hepatic Mitochondrial ND6 Provokes Systemic Insulin Resistance
Cao, K. J., Lv, W., Wang, X., Dong, S., Liu, X., Yang, T., Xu, J., Zeng, M., Zou, X., Zhao, D., et al. (2021) · Advanced Science · doi:10.1002/advs.202004507 · Cited by 63
Autonomic nerves and perivascular fat: Interactive mechanisms
Bulloch, J. M., & Daly, C. J. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.005 · Cited by 58
Ashworth, W. B., Davies, N. A., & Bogle, I. D. L. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005105 · Cited by 55
Ayoub, J. J., Abou-Samra, M., Hlais, S., Bassil, M. S., & Obeid, O. (2015) · Nutrition and Diabetes · doi:10.1038/nutd.2015.38 · Cited by 49
miR‑146a improves hepatic lipid and glucose metabolism by targeting MED1
Li, K., Zhao, B. L., Wei, D., Wang, W., Cui, Y., Qian, L., & Liu, G. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4443 · Cited by 52
In vivo 31 P magnetic resonance spectroscopy of the human liver at 7 T: an initial experience
Chmelík, M., Považan, M., Krššák, M., Gruber, S., Tkačov, M., Trattnig, S., & Bogner, W. (2014) · NMR in Biomedicine · doi:10.1002/nbm.3084 · Cited by 46
Self-citationHepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
Pan, X., & Zhang, Y. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002092 · Cited by 43
Valkovič, L., Chmelík, M., Ukropcová, B., Heckmann, T., Bogner, W., Frollo, I., Tschan, H., Krebs, M., Bachl, N., Ukropec, J., et al. (2016) · Scientific Reports · doi:10.1038/srep20087 · Cited by 42
Self-citationPetersen, K. F., Dufour, S., Mehal, W. Z., & Shulman, G. I. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.07.023 · Cited by 47
Wang, C., Tsai, T., & Wei, Y. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12838 · Cited by 38
Muyyarikkandy, M. S., McLeod, M., Maguire, M., Mahar, R., Kattapuram, N., Zhang, C., Surugihalli, C., Muralidaran, V., Vavilikolanu, K., Mathews, C. E., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001495r · Cited by 41
Geisler, C. E., Ghimire, S., Hepler, C., Miller, K. E., Bruggink, S. M., Kentch, K. P., Higgins, M. R., Banek, C. T., Yoshino, J., Klein, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109298 · Cited by 40
Wiafe, Y. A., Afihene, M., Anto, E. O., Nmai, R. A., Amoah-Kumi, L., Frimpong, J., Dickson, F. D., Antwi, S. O., & Roberts, L. R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113741 · Cited by 41
Wilk, A., Seichter, F., Kim, S.-S., Tütüncü, E., Mizaikoff, B., Vogt, J. A., Wachter, U. A., & Radermacher, P. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5524-z · Cited by 36
Acute exercise does not decrease liver fat in men with overweight or NAFLD
Bilet, L., Brouwers, B., van Ewijk, P. A., Hesselink, M. K. C., Kooi, M. E., Schrauwen, P., & Schrauwen-Hinderling, V. B. (2015) · Scientific Reports · doi:10.1038/srep09709 · Cited by 36
Valkovič, L., Gajdošík, M., Traussnigg, S., Wolf, P. S., Chmelík, M., Kienbacher, C., Bogner, W., Krebs, M., Trauner, M., Trattnig, S., et al. (2014) · European Radiology · doi:10.1007/s00330-014-3141-x · Cited by 41
Self-citationLund, M. T., Kristensen, M., Hansen, M., Tveskov, L., Floyd, A. K., Støckel, M., Vainer, B., Poulsen, S. S., Helge, J. W., Prats, C., et al. (2016) · The Journal of Physiology · doi:10.1113/jp272105 · Cited by 35
Ciaula, A. D., Calamita, G., Shanmugam, H., Khalil, M., Bonfrate, L., Wang, D. Q. ‐., Baffy, G., & Portincasa, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147702 · Cited by 36
Fritsch, M., Koliaki, C., Livingstone, R., Phielix, E., Bierwagen, A., Meisinger, M., Jelenik, T., Strassburger, K., Zimmermann, S., Brockmann, K., et al. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.107599 · Cited by 33
Self-citationMechanistic insights into the liver–brain axis during chronic liver disease
Siddle, M. R., Durán, R. G., Goel, D., Renquist, B. J., Holt, M. K., & Hadjihambi, A. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01142-z · Cited by 41
Sabatini, S., Sen, P., Carli, F., Pezzica, S., Rosso, C., Lembo, E., Verrastro, O., Daly, A. K., Govaere, O., Cockell, S., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101820 · Cited by 45
Rajendran, A., Soory, A., Khandelwal, N., Ratnaparkhi, G. S., & Kamat, S. S. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102128 · Cited by 36
Zamora, M., Pardo, R., & Villena, J. A. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.032 · Cited by 34
Gancheva, S., Bierwagen, A., Kaul, K., Herder, C., Nowotny, P., KAHL, S., Giani, G., Klüppelholz, B., Knebel, B., Begovatz, P., et al. (2016) · Diabetes · doi:10.2337/db16-0162 · Cited by 34
Self-citationQiu, B., Lawan, A., Xirouchaki, C. E., Yi, J.-S., Robert, M. E., Zhang, L., Brown, W. A., Fernandez-Hernando, C. F., Yang, X., Tiganis, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41145-5 · Cited by 37
Bu, S. Y., Kang, M., Kim, E., & Choi, M. (2012) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2012.17.2.093 · Cited by 37
Hepatic stress associated with pathologies characterized by disturbed glucose production
Gjorgjieva, M., Mithieux, G., & Rajas, F. (2019) · Cell Stress · doi:10.15698/cst2019.03.179 · Cited by 37
Metadata
- Authors
- Schmid, A. I., Szendroedi, J., Chmelik, M., Krššák, M., Moser, E., & Roden, M.
- Affiliations
- Medical University of Vienna (AT)
- Deutsches Diabetes-Zentrum e.V. (DE)
- MR Center of Excellence, Medical University of Vienna, Vienna, Austria
- Corresponding author
- Roden, Michael
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-01-20
- Volume
- 34
- Issue
- 2
- Pages
- 448-453
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3024365
- OpenAlex
- W2171705653
- Cited by
- 212
- References
- 24
- Citations by year
- 2026: 3 · 2025: 15 · 2024: 15 · 2023: 9 · 2022: 16 · 2021: 17 · 2020: 16 · 2019: 14 · 2018: 11 · 2017: 11 · 2016: 18 · 2015: 16 · 2014: 17 · 2013: 17 · 2012: 11
- FWCI
- 12.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Eli Lilly and Company
- GlaxoSmithKline
- European Foundation for the Study of Diabetes
- Deutsche Forschungsgemeinschaft (SFB 575, Project 13)
- Oesterreichische Nationalbank (OENB 11459)
- European Association for the Study of Diabetes
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes, insulin resistance, hepatic insulin sensitivity, hepatic steatosis, inorganic phosphate, hepatic energy metabolism, waist circumference, hyperinsulinemic-euglycemic clamp, 31P NMR
- MeSH terms
- Adenosine Triphosphate, Adipose Tissue, Blood Glucose, Diabetes Mellitus, Type 2, Energy Metabolism, Fatty Liver, Female, Humans, Insulin Resistance, Liver, Magnetic Resonance Imaging, Male, Middle Aged, Phosphorus Isotopes, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.